文献速递细菌感染、耐药与抗菌药物

DNA复制蛋白作为耐药细菌病原体抗菌药物潜在靶点的综述

DNA replication proteins as potential targets for antimicrobials in drug-resistant bacterial pathogens.
PubMed 文献 · J Antimicrob Chemother · 2017-01-01

该综述指出,抗菌药物耐药危机亟需新型抗菌药物,而DNA复制是细胞存活的必要条件,因而是有吸引力的抗菌靶点。尽管已开发出靶向DNA复制蛋白的抗菌药物,但临床广泛使用的仅促旋酶/拓扑异构酶抑制剂一类。细菌复制体上众多必需蛋白可作抑制剂靶点,但合适化合物相对匮乏,表明靶向复制体的抗菌药物研发仍不充分。

要点

  • DNA复制蛋白是抗菌药物开发的潜在靶点
  • 临床广泛使用的DNA复制靶向药物仅促旋酶/拓扑异构酶抑制剂
  • 靶向细菌复制体的抗菌药物研发仍不充分

核心结论

  • 靶向DNA复制蛋白的抗菌药物研发不足,复制体上众多必需蛋白可作潜在靶点但合适化合物匮乏。

研究设计与样本

  • 综述,报告靶向DNA复制的抗菌化合物的多样性并强调开发新药的挑战。

主要发现

  • DNA复制对细胞存活必需,是有吸引力的抗菌靶点。
  • 已开发的DNA复制蛋白靶向抗菌药物中,仅促旋酶/拓扑异构酶抑制剂在临床广泛使用。
  • 细菌复制体上众多必需蛋白可作抑制剂潜在靶点,但合适化合物相对匮乏。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

With the impending crisis of antimicrobial resistance, there is an urgent need to develop novel antimicrobials to combat difficult infections and MDR pathogenic microorganisms. DNA replication is essential for cell viability and is therefore an attractive target for antimicrobials. Although several antimicrobials targeting DNA replication proteins have been developed to date, gyrase/topoisomerase inhibitors are the only class widely used in the clinic. Given the numerous essential proteins in the bacterial replisome that may serve as a potential target for inhibitors and the relative paucity of suitable compounds, it is evident that antimicrobials targeting the replisome are underdeveloped so far. In this review, we report on the diversity of antimicrobial compounds targeting DNA replication and highlight some of the challenges in developing new drugs that target this process.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. van Eijk E, Wittekoek B, Kuijper EJ, et al. DNA replication proteins as potential targets for antimicrobials in drug-resistant bacterial pathogens. J Antimicrob Chemother. 2017. PMID: 28073967. doi:10.1093/jac/dkw548

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。